A
$ Value
$5.6M
Shares
1,075,000
Price
$5
Filed
Feb 6
Insider
Name
GOTTSCHALK ADRIAN
Title
Chief Executive Officer
CIK
0001828724
Roles
Director
Officer
Transaction Details
Transaction Date
2026-02-05
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,075,000
Footnotes
The option vests as to 25% of the underlying shares of common stock on February 5, 2027, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.
Filing Info
GOTTSCHALK ADRIAN's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-10 | FHTX | G | $0 |
| 2026-04-10 | FHTX | G | $0 |
| 2026-04-09 | FHTX | G | $0 |
| 2026-04-09 | FHTX | G | $0 |
| 2026-02-05 | FHTX | A | $5.6M |
| 2025-04-25 | FHTX | G | $0 |
| 2025-04-25 | FHTX | G | $0 |
Other Insiders at FHTX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Maynard Ryan D
Chief Financial Officer
|
— | — | 2026-02-23 |
|
Cardama Alfonso Quintas
Chief Medical Officer
|
— | — | 2026-01-30 |
|
GOTTSCHALK ADRIAN
Chief Executive Officer
|
— | — | 2026-04-10 |
|
Bellon Steven F.
Chief Scientific Officer
|
— | — | 2026-01-30 |
|
LaCascia Michael
Chief Legal Officer
|
— | — | 2026-01-30 |
|
Costa Carlos
Chief People Officer
|
— | — | 2026-01-30 |
|
Rivkin Anna
Chief Business Officer
|
— | — | 2026-01-30 |